Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V D Ramanathan

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Bacteriology|April 22, 2021
Correction for Singh et al., "Requirement of the <i>mymA</i> Operon for Appropriate Cell Wall Ultrastructure and Persistence of Mycobacterium tuberculosis in the Spleens of Guinea Pigs"Amit Singh, Radhika Gupta, R A Vishwakarma, et al.
Vaccine|August 23, 2011
Over-expression of superoxide dismutase obliterates the protective effect of BCG against tuberculosis by modulating innate and adaptive immune responsesRuchi Jain, Bappaditya Dey, Aparna Khera, et al.
Indian Journal of Leprosy|October 1, 1985
Studies on healthy contacts of leprosy patients--a preliminary reportG Ramu, G N Malaviya, V P Bharadwaj, et al.
Vaccine|October 20, 2009
Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in guinea pigsBappaditya Dey, Ruchi Jain, Aparna Khera, et al.
Vaccine|November 9, 2020
Corrigendum to 'Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis' [Vaccine 23 (2005) 5655-5665]Aparna Khera, Ramandeep Singh, H Shakila, et al.
Plos One|May 8, 2012
Appropriate DevR (DosR)-mediated signaling determines transcriptional response, hypoxic viability and virulence of Mycobacterium tuberculosisShyamasree De Majumdar, Atul Vashist, Sakshi Dhingra, et al.
Vaccine|September 15, 2005
Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosisAparna Khera, Ramandeep Singh, H Shakila, et al.
Plos One|December 5, 2008
Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lungRuchi Jain, Bappaditya Dey, Neeraj Dhar, et al.
Scandinavian Journal of Immunology|May 11, 2005
Increased expression of Mycobacterium tuberculosis 19 kDa lipoprotein obliterates the protective efficacy of BCG by polarizing host immune responses to the Th2 subtypeV Rao, N Dhar, H Shakila, et al.
Plos One|March 3, 2010
Co-expression of DevR and DevR(N)-Aph proteins is associated with hypoxic adaptation defect and virulence attenuation of Mycobacterium tuberculosisShyamasree De Majumdar, Deepak Sharma, Atul Vashist, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Bacteriology|April 22, 2021
Correction for Singh et al., "Requirement of the <i>mymA</i> Operon for Appropriate Cell Wall Ultrastructure and Persistence of Mycobacterium tuberculosis in the Spleens of Guinea Pigs"Amit Singh, Radhika Gupta, R A Vishwakarma, et al.
Vaccine|August 23, 2011
Over-expression of superoxide dismutase obliterates the protective effect of BCG against tuberculosis by modulating innate and adaptive immune responsesRuchi Jain, Bappaditya Dey, Aparna Khera, et al.
Indian Journal of Leprosy|October 1, 1985
Studies on healthy contacts of leprosy patients--a preliminary reportG Ramu, G N Malaviya, V P Bharadwaj, et al.
Vaccine|October 20, 2009
Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in guinea pigsBappaditya Dey, Ruchi Jain, Aparna Khera, et al.
Vaccine|November 9, 2020
Corrigendum to 'Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis' [Vaccine 23 (2005) 5655-5665]Aparna Khera, Ramandeep Singh, H Shakila, et al.
Plos One|May 8, 2012
Appropriate DevR (DosR)-mediated signaling determines transcriptional response, hypoxic viability and virulence of Mycobacterium tuberculosisShyamasree De Majumdar, Atul Vashist, Sakshi Dhingra, et al.
Vaccine|September 15, 2005
Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosisAparna Khera, Ramandeep Singh, H Shakila, et al.
Plos One|December 5, 2008
Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lungRuchi Jain, Bappaditya Dey, Neeraj Dhar, et al.
Scandinavian Journal of Immunology|May 11, 2005
Increased expression of Mycobacterium tuberculosis 19 kDa lipoprotein obliterates the protective efficacy of BCG by polarizing host immune responses to the Th2 subtypeV Rao, N Dhar, H Shakila, et al.
Plos One|March 3, 2010
Co-expression of DevR and DevR(N)-Aph proteins is associated with hypoxic adaptation defect and virulence attenuation of Mycobacterium tuberculosisShyamasree De Majumdar, Deepak Sharma, Atul Vashist, et al.
Pageof 6